Newsfeeds - Spark Newswire

2 minute read

FDA
News

Allogene Reports Receives FDA Orphan Drug Designation For ALLO-715 For Treatment Of Multiple Myeloma

Today, 11:10 AM

ODD Follows RMAT Designation Granted to ALLO-715 by the U.S. Food and Drug Administration in Multiple Myeloma Patients Phase 1 Data from the ALLO-715 UNIVERSAL Trial Demonstrated for the First Time that an Allogeneic

ALLO

5 minute read

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma

By Shanthi Rexaline

Today, 11:10 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11)

ABCL

1 minute read

Allogene Therapeutics Q2 EPS $(0.53) Beats $(0.55) Estimate, Sales $44.00K

By Benzinga Newsdesk

Today, 11:10 AM

Allogene Therapeutics (NASDAQ:ALLO) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.55) by 3.64 percent. This is unchanged from the same period last year. The company

ALLO

24 minute read

Earnings Scheduled For August 4, 2021

By Benzinga Insights

Today, 11:10 AM

Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.

ABC

5 minute read

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen’s Anemia Drug, Corvus Shelves COVID Study

By Shanthi Rexaline

Today, 11:10 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15)

ABCL

11 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 11:10 AM

During the morning session on Thursday, 152 stocks hit new 52-week lows.

ABCL

6 minute read

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs

By Shanthi Rexaline

Today, 11:10 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14)

ABCL

5 minute read

The Daily Biotech Pulse: Lilly, Morphic’s Positive Data At ECCO, Humanigen’s COVID Treatment Gets Expedited Review In UK, TransCode IPO

By Shanthi Rexaline

Today, 11:10 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8)

ABCL

2 minute read

Allogene Therapeutics Granted FDA Fast Track Designation For ALLO-605, A TurboCAR T Cell Therapy, For The Treatment Of Relapsed/Refractory Multiple Myeloma

By Bill Haddad

Today, 11:10 AM

Phase 1 IGNITE Dose Escalation Trial of ALLO-605 Initiated in Q2 2021 ALLO-605 is the Third Prong of the Company's Clinical Strategy to Target BCMA for the Treatment of Multiple

ALLO

5 minute read

The Daily Biotech Pulse: Lilly Spikes On Alzheimer’s Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO

By Shanthi Rexaline

Today, 11:10 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23)

ABCL